{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:26:10Z","timestamp":1792056370288,"version":"4.4.0"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,11,11]],"date-time":"2003-11-11T00:00:00Z","timestamp":1068508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2004,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>For many migraine patients, triptan therapy provides complete pain relief in some attacks but not in others. Here, we tested whether the success of triptan therapy is hindered in the presence of cutaneous allodynia (pain resulting from a nonnoxious stimulus to normal skin), a phenomenon we previously described develop gradually during the course of the migraine attack in more than 70% of patients. We studied migraine patients repeatedly on three visits to the clinic: in the absence of migraine (baseline), within the first hour of one attack, or at 4 hours from onset of another attack. Presence or absence of allodynia was determined based on differences between migraine and baseline pain thresholds to mechanical and thermal stimulation of periorbital skin. In 31 patients, we studied 34 migraine attacks that were associated with allodynia at the time of triptan treatment and 27 attacks that were not. Within 2 hours of triptan treatment, patients were rendered pain\u2010free in 5 of 34 (15%) of allodynic attacks versus 25 of 27 (93%) of nonallodynic attacks. Treating migraine attacks 1 hour (early) or 4 hours (late) after the onset of pain was equally ineffective in inducing a pain\u2010free state in the presence of allodynia, and equally effective in the absence of allodynia. For patients susceptible to allodynia during the attack, triptan therapy was by far more likely to provide complete pain relief if administered before rather than after the establishment of cutaneous allodynia. Patients who never developed allodynia were highly likely to be rendered pain\u2010free by triptan therapy anytime after the onset of pain. We conclude that the probability of consistent pain\u2010free outcome increases drastically if triptan therapy is vigilantly timed to precede any signs of cutaneous allodynia. Ann Neurol 2004;55:000\u2013000<\/jats:p>","DOI":"10.1002\/ana.10786","type":"journal-article","created":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T09:34:51Z","timestamp":1072863291000},"page":"19-26","source":"Crossref","is-referenced-by-count":521,"title":["Defeating migraine pain with triptans: A race against the development of cutaneous allodynia"],"prefix":"10.1002","volume":"55","author":[{"given":"Rami","family":"Burstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,11,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480010072027"},{"key":"e_1_2_6_3_2","first-page":"345","volume-title":"The headaches","author":"Olesen J","year":"2000"},{"key":"e_1_2_6_4_2","first-page":"337","volume-title":"The headaches","author":"Zagami AS","year":"2000"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/384560a0"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1998.79.2.964"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.8.1703"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00478-4"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(91)90630-B"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90005-A"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079904X15200"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.10.1511"},{"key":"e_1_2_6_14_2","first-page":"1","article-title":"Classification and diagnosis criteria for headache disorders, cranial neuralgia and facial pain","volume":"8","author":"Headache\u2010classification\u2010committee\u2010of\u2010the\u2010International\u2010Headache\u2010Society","year":"1988","journal-title":"Cephalalgia"},{"key":"e_1_2_6_15_2","series-title":"The headaches","first-page":"411","author":"Saxena PR","year":"2000"},{"key":"e_1_2_6_16_2","first-page":"328","article-title":"Physicochemical comparison of eletriptan and other 5\u2010HT1D\u2010like agonists as a predictor of oral absorption potential","volume":"37","author":"Rance D","year":"1997","journal-title":"Headache"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.39.11.1071"},{"key":"e_1_2_6_18_2","series-title":"Touch, temperature and pain in health and disease: mechanism and assessments","first-page":"63","author":"Lindblom U","year":"1994"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00099-8"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200003000-00014"},{"key":"e_1_2_6_21_2","volume-title":"Biostatistical analysis","author":"Zar JH","year":"1998"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80083-1"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1993.tb00732.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.1998.550469.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.5.1210"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.1998.560535.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3810748.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2001.00218.x"},{"key":"e_1_2_6_29_2","article-title":"Defeating intracranial pain with triptan in an animal model of migraine: a race against developing central sensitization and cutaneous allodynia","author":"Burstein R","year":"2003","journal-title":"Ann Neurol"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.10786","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.10786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T02:25:50Z","timestamp":1695954350000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.10786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1002\/ana.10786"],"URL":"https:\/\/doi.org\/10.1002\/ana.10786","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,11]]}}}